Skip to main content

2023

BC Kidney Research in Focus, published twice per year, highlights research and quality improvement by BC kidney health professionals, as well as patient partners on research teams.

 

 

Study reveals ways to better support kidney patients in home blood pressure monitoring<img alt="" src="/PublishingImages/research/Blood%20pressure.jpg" style="BORDER:0px solid;" />Study reveals ways to better support kidney patients in home blood pressure monitoringhttp://www.bcrenal.ca/research/bc-kidney-research-in-focus/2023/study-reveals-ways-to-better-support-kidney-patients-in-home-blood-pressure-monitoring2023-05-10T07:00:00Z
New tools help hemodialysis patients understand which medications can be stopped safely<img alt="" src="/PublishingImages/research/Deprescribing.jpg" style="BORDER:0px solid;" />New tools help hemodialysis patients understand which medications can be stopped safelyhttp://www.bcrenal.ca/research/bc-kidney-research-in-focus/2023/new-tools-help-hemodialysis-patients-understand-which-medications-can-be-stopped-safely2023-05-10T07:00:00Z
Program that support patients in receiving dialysis at home proves successful<img alt="" src="/PublishingImages/research/PD%20Assist%20Program.png" style="BORDER:0px solid;" />Program that support patients in receiving dialysis at home proves successfulhttp://www.bcrenal.ca/research/bc-kidney-research-in-focus/2023/program-that-support-patients-in-receiving-dialysis-at-home-proves-successful2023-05-10T07:00:00Z
A small subset of GN patients shows mild and manageable disease flares after vaccination<img alt="" src="/PublishingImages/research/GN%20and%20Vaccines.jpg" style="BORDER:0px solid;" />A small subset of GN patients shows mild and manageable disease flares after vaccinationhttp://www.bcrenal.ca/research/bc-kidney-research-in-focus/2023/a-small-subset-of-gn-patients-show-mild-and-manageable-disease-flares-after-vaccination2023-05-10T07:00:00Z
SGLT2 inhibitor drugs expected to reduce need for dialysis and related health-care costs<img alt="" src="/PublishingImages/research/SGLT2-inhibitors.jpg" style="BORDER:0px solid;" />SGLT2 inhibitor drugs expected to reduce need for dialysis and related health-care costshttp://www.bcrenal.ca/research/bc-kidney-research-in-focus/2023/sglt2-inhibitor-drugs-expected-to-reduce-need-for-dialysis-and-related-health-care-costs2023-05-10T07:00:00Z
Researcher profile: Malak Ghaddar<img alt="" src="/PublishingImages/research/Malak%20profile.jpg" style="BORDER:0px solid;" />Researcher profile: Malak Ghaddarhttp://www.bcrenal.ca/research/bc-kidney-research-in-focus/2023/researcher-profile-malak-ghaddar2023-05-10T07:00:00Z
Large study confirms SGLT2 inhibitor drugs are beneficial for kidney patients<img alt="" src="/PublishingImages/research/EMPA%20results.png" style="BORDER:0px solid;" />Large study confirms SGLT2 inhibitor drugs are beneficial for kidney patientshttp://www.bcrenal.ca/research/bc-kidney-research-in-focus/2023/large-study-confirms-sglt2-inhibitor-drugs-are-beneficial-for-kidney-patients2023-05-10T07:00:00Z


SOURCE: 2023 ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Renal. All Rights Reserved.

    Copyright © 2023 Provincial Health Services Authority